ArticlePharmacological research2016

The thiirane-based selective MT1-MMP/MMP2 inhibitor ND-322 reduces melanoma tumor growth and delays metastatic dissemination.

Charles Marusak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.